Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

10661studies shown

Showing 8,785-8,796 of 10,661

Behavioral study icon

CompletedNCT00258479

Safety of Combining Modafinil and Nicotine Replacement Therapy in Treating Nicotine Dependent Adolescents

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionBehavioralFrom 16 Years to 40 Years

Countries: United States
Sponsor: Catherine Martin, MD
Condition: Addiction

Drug study icon

CompletedNCT04855760

Safety of REL-1017 for Major Depressive Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In United States

DepressionDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Relmada Therapeutics, Inc.
Condition: Depression

Behavioral study icon

CompletedNCT03655470

Safety Planning in Juvenile Justice for Suicidal Youth

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SuicidalityBehavioralFrom 12 Years to 18 Years

Countries: United States
Sponsor: Brown University
Condition: Suicidality

Behavioral study icon

Enrolling By InvitationNCT05307432

Safety Planning Intervention Telehealth Service Model in Emergency Departments

This summary needs review. Please check the official study record and contact the research team for details.

Remote / online

SuicidalityBehavioralOver 18 Years

Countries: United States
Sponsor: University of Pennsylvania
Condition: Suicidality

Behavioral study icon

CompletedNCT03227991

Safety Planning Intervention to Reduce Short Term Risk

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SuicidalityBehavioralOver 18 Years

Countries: United States
Sponsor: New York State Psychiatric Institute
Condition: Suicidality

Drug study icon

CompletedNCT00516386

Safety Profile of Insulin Like Growth Factor-1 (IGF-I) Administration in Adolescents

This summary needs review. Please check the official study record and contact the research team for details.

In United States

Eating disordersDrugFrom 12 Years to 18 Years

Countries: United States
Sponsor: Massachusetts General Hospital
Condition: Eating disorders

Drug study icon

CompletedNCT00628420

Safety Study of ACP-104: To Demonstrate the Safety, Tolerability, and Pharmacokinetics

This study is completed in the United States. It focuses on Schizophrenia.

In United States

SchizophreniaDrugFrom 20 Years to 50 Years

Countries: United States
Sponsor: University of Texas Southwestern Medical Center
Condition: Schizophrenia

Drug study icon

CompletedNCT00634439

Safety Study of Atomoxetine and Cerebrovascular Outcomes

This summary needs review. Please check the official study record and contact the research team for details.

In United States

ADHDDrugOver 18 Years

Countries: United States
Sponsor: Eli Lilly and Company
Condition: ADHD

Drug study icon

WithdrawnNCT01075126

Safety Study of Depakote Versus Lithium in African Americans With Bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In United States

BipolarityDrugFrom 18 Years to 60 Years

Countries: United States
Sponsor: Lawson, William B., M.D., PhD, DFAPA
Condition: Bipolarity

Drug study icon

CompletedNCT00829777

Safety Study of Intravenous 6β-Naltrexol (AIKO-150) in Opioid-Dependent Subjects

This summary needs review. Please check the official study record and contact the research team for details.

In United States

AddictionDrugFrom 21 Years to 45 Years

Countries: United States
Sponsor: California Pacific Medical Center Research Institute
Condition: Addiction

Drug study icon

CompletedNCT00190749

Safety Study of Olanzapine and a Comparator in people with Schizophrenia and Schizoaffective Disorder

This summary needs review. Please check the official study record and contact the research team for details.

In United States

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Eli Lilly and Company
Condition: Schizophrenia

Drug study icon

CompletedNCT02155829

Safety Study of Riluzole to Treat PTSD (PTSD)

This summary needs review. Please check the official study record and contact the research team for details.

In United States

PTSDDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Uniformed Services University of the Health Sciences
Condition: PTSD

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.